DLA
CASM

Douglas Lane & Associates’s CAS Medical Systems, Inc. CASM Stock Holding History

Douglas Lane & Associates’s Portfolio CASM Stock Details CASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-33,774
Closed -$54K – 225
2018
Q4 		$54K Buy
+33,774
New +$62.9K ﹤0.01% 215

Other funds holding CASM

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
SAM
SignalPoint Asset Management Springfield, Missouri $411M AUM 23.81% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Douglas Lane & Associates's CASM Position: Q1 2019 in Review

Douglas Lane & Associates sold out of CAS Medical Systems, Inc. (CASM) in Q1 2019, closing a stake of 33,774 shares — an estimated $54K sold.

Douglas Lane & Associates first reported a position in CASM in Q4 2018 and held it in 1 quarter. The position peaked at $54K in Q4 2018. 32 funds tracked by Wall St. Rank hold CASM as of Q1 2019.

  • Douglas Lane & Associates reported no remaining CAS Medical Systems, Inc. position as of Q1 2019 after selling out during the quarter.
  • Douglas Lane & Associates sold 33,774 CAS Medical Systems, Inc. shares in Q1 2019, an estimated $54K.
  • Douglas Lane & Associates first reported a position in CAS Medical Systems, Inc. in Q4 2018 and held it in 1 quarter.
  • Douglas Lane & Associates's CAS Medical Systems, Inc. position peaked at $54K in Q4 2018.
  • 32 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q1 2019.

Based on Douglas Lane & Associates's 13F filing for Q1 2019, filed 23 Apr 2019.